Brian Lannutti

Brian Lannutti is an accomplished executive in the field of biomedical research and development, currently serving as Executive Vice President of Research and Development at Solve Therapeutics, Inc. since November 2021. Prior to this role, Brian held various senior positions, including Senior Vice President of Research and Development at VelosBio Inc., Chief Scientific Officer at Oncternal Therapeutics, and Senior Vice President of Translational Science at Acerta Pharma B.V. With a strong foundation in oncology research developed during tenure at Gilead Sciences and Calistoga Pharmaceuticals, Brian also contributed to academia as an Assistant Professor at the University of Washington's School of Medicine.